DR. JAMES CORYDON VARY, MD, PHD
Dermatology in Seattle, WA

License number
Washington MD 60083439
Category
Osteopathic Medicine
Type
Dermatology
Address
Address
Ne - FLOOR 4TH, Seattle, WA 98105
Phone
(206) 598-5065
(206) 598-4768 (Fax)

Personal information

See more information about JAMES CORYDON VARY at radaris.com
Name
Address
Phone
James Vary
1117 NE Ravenna Blvd, Seattle, WA 98105
(425) 445-7382
James C Vary, age 53
8201 15Th St, Seattle, WA 98115
(206) 985-0995

Professional information

James C Vary Photo 1

Dr. James C Vary, Seattle WA - MD (Doctor of Medicine)

Specialties:
Dermatology
Address:
4225 Roosevelt Way NE SUITE 4TH, Seattle 98105
(206) 598-5065 (Phone), (206) 598-4768 (Fax)
UNIV OF WASHINGTON MEDICAL CTR
4225 Roosevelt Way NE SUITE 101, Seattle 98105
(206) 598-4225 (Phone), (206) 598-4768 (Fax)
Certifications:
Dermatology, 2009
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Washington
Graduated: 1999


James Vary Photo 2

James Vary, Seattle WA

Specialties:
Dermatology, Internal Medicine
Work:
Dermatology Clinic at Uwmc Roosevelt
4 Roosevelt Way NE, Seattle, WA 98105 University of Washington
1959 Ne Pacific St, Seattle, WA 98195
Education:
University of Washington (2005)


James Vary Photo 3

Escherichia Coli O157:H7 Epithelial Adhesion And Vaccine

US Patent:
6040421, Mar 21, 2000
Filed:
Jun 16, 1998
Appl. No.:
9/098082
Inventors:
Phillip I. Tarr - Seattle WA
Sima S. Bilge - Bellevue WA
Thomas E. Besser - Moscow ID
James C. Vary - Seattle WA
Assignee:
Children's Hospital and Medical Center - Seattle WA
University of Washington - Seattle WA
University Research Foundation - Pullman WA
International Classification:
A61K 3800, A61K 3902, A61K 39108, A61K 3900, C07C24500
US Classification:
530300
Abstract:
Polypeptides encoded by a continuous segment of chromosomal DNA from E. coli O157:H7, isolated on plasmid pSC(overlap) (ATCC No. 69648), that encodes an adhesin (SEQ ID NO:5) that mediates bacterial colonization of bovine intestines, vaccines derived therefrom, and antibodies directed against the adhesin.


James Vary Photo 4

Escherichia Coli O157:H7 Epithelial Adhesin

US Patent:
5798260, Aug 25, 1998
Filed:
Mar 26, 1997
Appl. No.:
8/765081
Inventors:
Phillip I. Tarr - Seattle WA
Sima S. Bilge - Bellevue WA
Thomas E. Besser - Moscow ID
James C. Vary - Seattle WA
Assignee:
Children's Hospital and Medical Center - Seattle WA
University of Washington - Seattle WA
Washington State University Research Foundation - Pullman WA
International Classification:
C12N 121, C12N 1563, C07H 2104
US Classification:
4352523
Abstract:
A continuous segment of chromosomal DNA from E. coli O157:H7, isolated on plasmid pSC(overlap) (ATCC No. 69648), encodes an adhesin (SEQ ID NO:4) that mediates bacterial colonization of bovine intestines.


James Vary Photo 5

Nucleic Acid Probes For Detecting E. Coli O157:H7

US Patent:
5654417, Aug 5, 1997
Filed:
Apr 14, 1995
Appl. No.:
8/423564
Inventors:
Phillip I. Tarr - Seattle WA
Sima S. Bilge - Bellevue WA
James C. Vary - Seattle WA
Assignee:
Children's Hospital and Medical Center - Seattle WA
University of Washington - Seattle WA
International Classification:
C07H 2104, C12Q 168
US Classification:
536 2432
Abstract:
An isolated nucleic acid molecule that hybridizes under stringent conditions to SEQ ID NO:1 or its complement and to the DNA of enterohemorrhagic E. coli O157:H7 but not to the DNA of enteropathogenic E. coli O55:H7.


James Vary Photo 6

Escherichia Coli O157:H7 Epithelial Adhesin

US Patent:
2005007, Apr 7, 2005
Filed:
Jul 23, 2003
Appl. No.:
10/625972
Inventors:
Phillip Tarr - Seattle WA, US
Sima Bilge - Bellevue WA, US
Thomas Besser - Moscow ID, US
James Vary - Seattle WA, US
International Classification:
A61K039/00, A61K039/38
US Classification:
424184100
Abstract:
Polypeptides encoded by a continuous segment of chromosomal DNA from O157:H7, isolated on plasmid pSC(overlap)(ATCC No. 69648), that encodes an adhesin (SEQ ID NO:5) that mediates bacterial colonization of bovine intestines, vaccines derived therefrom, and antibodies directed against the adhesin are disclosed.